p38 MAPK inhibition improves synaptic plasticity and memory in angiotensin II-dependent hypertensive mice

Hai-Long Dai, Wei Yuan Hu, Li Hong Jiang, Le-Yu Li, Xue Feng Gaung, Zhi-cheng Xiao

Research output: Contribution to journalArticleResearchpeer-review

17 Citations (Scopus)

Abstract

The pathogenesis of hypertension-related cognitive impairment has not been sufficiently clarified, new molecular targets are needed. p38 MAPK pathway plays an important role in hypertensive target organ damage. Activated p38 MAPK was seen in AD brain tissue. In this study, we found that long-term potentiation (LTP) of hippocampal CA1 was decreased, the density of the dendritic spines on the CA1 pyramidal cells was reduced, the p-p38 protein expression in hippocampus was elevated, and cognitive function was impaired in angiotensin II-dependent hypertensive C57BL/6 mice. In vivo, using a p38 heterozygous knockdown mice (p38 KI/+) model, we showed that knockdown of p38 MAPK in hippocampus leads to the improvement of cognitive function and hippocampal synaptic plasticity in angiotensin II-dependent p38 KI/+ hypertensive mice. In vitro, LTP was improved in hippocampal slices from C57BL/6 hypertensive mice by treatment with p38MAPK inhibitor SKF86002. Our data demonstrated that p38 MAPK may be a potential therapeutic target for hypertension-related cognitive dysfunction.

Original languageEnglish
Article number27600
Number of pages10
JournalScientific Reports
Volume6
DOIs
Publication statusPublished - 10 Jun 2016

Cite this